Skip to content

Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices

Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices Under X-ray Perspective

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06670157
Enrollment
6
Registered
2024-11-01
Start date
2024-05-01
Completion date
2025-10-30
Last updated
2024-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Varices Bleeding

Brief summary

A single-arm exploratory clinical study design was used to evaluate the safety and efficacy of a modified sandwich injection of tissue glue assisted by a detachable clip for the treatment of gastric varicose veins.

Interventions

OTHERDetachable Clip

After the varicose vessels basically disappeared under the endoscope, the removable titanium clamp was removed

Sponsors

Yu Chang
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The subject voluntarily signs the informed consent for this experiment; According to clinical manifestation, laboratory examination, imaging examination, or liver biopsy in the diagnosis of liver cirrhosis patients; The endoscopy diagnosed gastric varices (gastroesophageal varices, gastroesophageal varices type 2 or type 1 isolated gastric varices type 1); High risk of gastric varices or has a history of gastric varices bleeding. The initial fluid resuscitation patients before or after the recovery hemodynamic stability; The age of 18 years old or more.

Exclusion criteria

* \< 18 years old; Regional portal hypertension; Always have a liver transplant, via the jugular intrahepatic portal vein system bypass or splenectomy combined varices cut-out art history; A concurrent hepatorenal syndrome and/or multiple organ failure; Significant impact on survival of malignant tumor; Pregnancy or lactation; A known allergy to iodine.

Design outcomes

Primary

MeasureTime frame
Rebleeding rate at 6 weeks after treatment for gastric fundus varicose veins in cirrhosis6 weeks

Countries

China

Contacts

Primary Contactji xuan, doctor
changgyuu@163.com13140718720
Backup Contactyu chang, master
18175226948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026